Table 4.
ABR | β Coefficient (P Value) | ||||
---|---|---|---|---|---|
Overall | Source | Setting | |||
Respiratory | Nonrespiratory | Ambulatory | Inpatient | ||
Gram-Positive ABR per 100 Admissions | |||||
MRSA | 0.060 (0.615) | 0.066 (0.028) | −0.087 (0.065) | NA | NA |
Macrolide-NS Streptococcus pneumoniae | 0.464 (<0.001) | 0.253 (<0.001) | 0.068 (0.376) | NA | NA |
Penicillin-NS S pneumoniae | 0.062 (0.011) | 0.056 (0.046) | 0.044 (0.103) | NA | NA |
ESC-NS S pneumoniae | 0.033 (0.036) | 0.032 (0.012) | 0.018 (0.073) | NA | NA |
Gram-Negative ABR Percent NS | |||||
FQ-NS ENT | 0.041 (<0.001) | 0.130 (<0.001) | 0.031 (0.030) | 0.018 (0.043) | 0.048 (<0.001) |
FQ-NS PSA | 0.039 (0.015) | 0.022 (0.036) | 0.020 (0.087) | 0.032 (0.172) | 0.044 (0.015) |
Carb-NS ACB | 0.205 (<0.001) | 0.379 (<0.001) | 0.134 (0.040) | 0.123 (0.077) | 0.255 (<0.001) |
Abbreviations: ABR antibiotic resistance; ACB, Acinetobacter spp; Carb, carbapenem; ENT, Enterobacterales; ESC, extended-spectrum cephalosporin; FQ, fluoroquinolone; MRSA, methicillin-resistant Staphylococcus aureus; NA, not applicable; NS, not susceptible; PSA, Pseudomonas aeruginosa.
Data were adjusted for region, teaching status, urban/rural location, bed size, and season.
NOTE: Statistically significant findings are shown in bold.